Literature DB >> 25280490

Updated product label allows home administration of omacetaxine mepesuccinate.

Ann Q Shen1, Mihaela Munteanu2, Hanna Jean Khoury1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25280490      PMCID： PMC4221374          DOI： 10.1634/theoncologist.2014-0230

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  1 in total

1.  U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia.

Authors:  Firoozeh Alvandi; Virginia E Kwitkowski; Chia-Wen Ko; Mark D Rothmann; Stacey Ricci; Haleh Saber; Debasis Ghosh; Janice Brown; Erika Pfeiler; Elsbeth Chikhale; Joseph Grillo; Julie Bullock; Robert Kane; Edvardas Kaminskas; Ann T Farrell; Richard Pazdur
Journal:  Oncologist       Date:  2013-12-05
  1 in total
  1 in total

Review 1.  Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application.

Authors:  Ana M L Seca; Diana C G A Pinto
Journal:  Int J Mol Sci       Date:  2018-01-16       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.